| P50 | author | Omar Niss | Q39273882 |
| P2093 | author name string | Punam Malik | |
| | Parul Rai | |
| P2860 | cites work | Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members | Q30459060 |
| | Stroke prevention and treatment in sickle cell disease | Q30646874 |
| | Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy | Q33145693 |
| | Conduction abnormalities in pediatric patients with restrictive cardiomyopathy | Q33160882 |
| | Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom | Q33837174 |
| | Improved survival of children and adolescents with sickle cell disease | Q33839801 |
| | High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension | Q33997180 |
| | Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. | Q33997200 |
| | Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies | Q34038886 |
| | Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment | Q34187983 |
| | Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension | Q34436782 |
| | Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review | Q34470834 |
| | Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition. | Q34786236 |
| | Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years | Q34806446 |
| | Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In | Q34999923 |
| | Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy | Q35078958 |
| | Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity | Q35140978 |
| | Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom | Q35243386 |
| | Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension | Q35435386 |
| | Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease | Q35576474 |
| | Laboratory and echocardiography markers in sickle cell patients with leg ulcers | Q35632843 |
| | Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial | Q35740419 |
| | Hepcidin in iron overload disorders | Q35847742 |
| | Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease | Q35892520 |
| | Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin | Q35990633 |
| | Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease | Q36151344 |
| | Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension | Q36330543 |
| | Mortality in adults with sickle cell disease and pulmonary hypertension | Q36436649 |
| | Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. | Q36577872 |
| | Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease | Q36677950 |
| | Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review | Q36831598 |
| | Pulmonary hypertension and erythropoietin | Q36857907 |
| | Hemodynamic predictors of mortality in adults with sickle cell disease | Q36999803 |
| | Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation | Q37112890 |
| | Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology | Q37258558 |
| | Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension | Q37287183 |
| | Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study | Q37328944 |
| | Right and left ventricular function and myocardial scarring in adult patients with sickle cell disease: a comprehensive magnetic resonance assessment of hepatic and myocardial iron overload | Q37359908 |
| | Cardiovascular abnormalities in sickle cell disease | Q37435068 |
| | Echocardiographic findings in patients with sickle cell disease | Q37504776 |
| | Splenectomy is modifying the vascular remodeling of thrombosis | Q37648414 |
| | Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease. | Q37650448 |
| | An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease | Q37698249 |
| | Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography | Q38016110 |
| | Pulmonary hypertension due to left heart diseases. | Q38172722 |
| | Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. | Q38467055 |
| | Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients | Q38471171 |
| | Myocardial infarction in sickle cell anemia | Q40116504 |
| | Iron overload cardiomyopathies: new insights into an old disease | Q40702958 |
| | Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment | Q40738128 |
| | Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea. | Q40895215 |
| | Abnormal myocardial perfusion-fibrosis pattern in sickle cell disease assessed by cardiac magnetic resonance imaging | Q43498870 |
| | Left ventricular filling in sickle cell anemia | Q43503725 |
| | Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival | Q44189785 |
| | The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom. | Q44618194 |
| | Pulmonary hypertension as a risk factor for death in patients with sickle cell disease | Q44777573 |
| | Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy | Q44864380 |
| | Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival. | Q45950077 |
| | Acute myocardial infarction in hemoglobin SC disease | Q46501255 |
| | Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension | Q46892378 |
| | Echocardiographic abnormalities in sickle cell disease | Q47271610 |
| | Pulmonary hypertension in sickle cell disease | Q47907825 |
| | Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients | Q47914412 |
| | Pulmonary hypertension in children and adolescents with sickle cell disease | Q48460721 |
| | A hemodynamic study of pulmonary hypertension in sickle cell disease | Q49084691 |
| | Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. | Q51541825 |
| | Causes of death in sickle cell disease: an autopsy study | Q51650014 |
| | Circumstances of death in adult sickle cell disease patients. | Q51789812 |
| | Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. | Q52422731 |
| | Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. | Q52430457 |
| | Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. | Q52431887 |
| | Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. | Q53615283 |
| | Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes | Q57450065 |
| | Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology | Q57824349 |
| | Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease | Q58862358 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P577 | publication date | 2017-04-28 | |
| P1433 | published in | Pediatric Blood & Cancer | Q15754342 |
| P1476 | title | A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia | |